SCHEMBL15434893

SCHEMBL15434893

COC(=O)c1ccccc1N1c2ccccc2N(c2ccccc2-c2ccccc2)c2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.53
SLC6A3 Q01959 5/20 0.51
SLC6A4 P31645 3/20 0.51
SMN1; SMN2 Q16637 1/20 0.49
POLB P06746 2/20 0.48
GABRA1 P14867 1/20 0.48
GABRG2 P18507 1/20 0.48
GABRB3 P28472 1/20 0.48
GABRA3 P34903 1/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
MGLL Q99685 1/20 0.46
SLC6A2 P23975 1/20 0.46
TSHR P16473 2/20 0.45
LMNA P02545 1/20 0.45
ALDH1A1 P00352 1/20 0.44
CFTR P13569 1/20 0.44
HSD17B10 Q99714 1/20 0.44
FGFR1 P11362 1/20 0.43
SRC P12931 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15434915 0.87 MYC (0.66) MYCSLC6A3SMN1; SMN2POLBMEN1
SCHEMBL17882410 0.83 NR4A2 (0.46) MYCSLC6A3SLC6A4SMN1; SMN2POLB
SCHEMBL1775832 0.80 SLC6A3 (0.74) SLC6A3SLC6A4SMN1; SMN2POLBGABRA1
Phosphine SCHEMBL11469830 0.79 SLC6A3 (0.72) SLC6A3SLC6A4SMN1; SMN2POLBGABRA1
Bicarbonate SCHEMBL27467504 0.79 SLC6A3 (0.72) SLC6A3SLC6A4SMN1; SMN2POLBGABRA1
SCHEMBL24891060 0.78 MYC (0.49) MYCSLC6A3SLC6A4SMN1; SMN2POLB
SCHEMBL31318316 0.77 SLC6A3 (0.78) SLC6A3SLC6A4SMN1; SMN2POLBGABRA1
SCHEMBL22256434 0.77 SLC6A3 (0.65) SLC6A3SLC6A4SMN1; SMN2POLBGABRA1
SCHEMBL22256425 0.77 SLC6A3 (0.65) SLC6A3SLC6A4SMN1; SMN2POLBGABRA1
SCHEMBL31109161 0.77 SLC6A3 (0.65) SLC6A3SLC6A4SMN1; SMN2POLBGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10622567-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2020-04-14 US disclosed
EP-2872589-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-07-26 EP disclosed
US-20150295186-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-10-15 US disclosed
US-20150295186-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-10-15 US disclosed
US-20150295186-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-10-15 US disclosed
WO-2014008967-A2 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2014-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150295186-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, EPCAM, OR10J3 MYC 1028/4885SLC6A3 1562/4885SLC6A4 2281/4885
US-10622567-B2 Materials for organic electroluminescent devices L1CAM, EPCAM, OR10J3 MYC 1028/4885SLC6A3 1562/4885SLC6A4 2281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.